ECONOMIC BURDEN OF SALMONELLA INFECTIONS IN THE UNITED STATES

The aim of this study is to evaluate medical expenditures and lost productivity associated with burden of Salmonella infections. We used laboratory confirmed number of Salmonella cases and corresponding multipliers to estimate the burden of illness using the method adopted by Foodborne Diseases Active Surveillance Network (FoodNet) at Centers for Disease Control and Prevention (CDC). The medical costs estimates are retrospective analysis of reimbursement records from MarketScan data. We identified patients with a diagnosis of salmonellosis using ICD-9 CM codes from the MarketScan 1993-2001 databases. Productivity loss from the nonfatal cases of Salmonella was calculated using the distributions of lost workdays and household services due to the illness. Statistical value of life approach was used to estimate the costs due to premature deaths. We also compared the costs for the gastrointestinal salmonellosis to the cost for the invasive salmonellosis. Confidence intervals around the cost estimates were calculated using a Monte Carlo simulation technique. Estimated average economic burden due to Salmonella was $210 per outpatient,$5,797 per inpatient with gastrointestinal infection, $16,441 per impatient with invasive infection and$4.63 million per premature death. Total economic buren due to Salmonella in the United States was estimated at $2.8 billion (95$1.6 to $5.3 billion) annually, which is approximately$2,472 per case of Salmonella infection. The cost estimate is largely driven by the number of premature deaths followed by average cost of hospitalization. Defining the risk factors for fatal outcomes may help target treatment and preventive strategies.Food Consumption/Nutrition/Food Safety,

Preliminary foodnet data on the incidence of foodborne infection, 10 US sites 2004

The 2004 data indicate declines in the incidence of infections caused by Campylobacter, Cryptosporidium, Shiga toxin--producing Escherichia coli (STEC) O157, Listeria, Salmonella, and Yersinia. Declines in Campylobacter and Listeria incidence are approaching national health objectives (objectives 10-1a through 1d); for the first time, the incidence of STEC O157 infections in FoodNet is below the 2010 target (U.S. Department of Health and Human Services 2000, U.S. Department of Agriculture 2003)(Table)

World Health Organization Ranking of Antimicrobials According to Their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies for the Use of Antimicrobials in Food Production Animals

The use of antimicrobials in food animals creates an important source of antimicrobial-resistant bacteria that can spread to humans through the food supply. Improved management of the use of antimicrobials in food animals, particularly reducing the usage of those that are "critically important” for human medicine, is an important step toward preserving the benefits of antimicrobials for people. The World Health Organization has developed and applied criteria to rank antimicrobials according to their relative importance in human medicine. Clinicians, regulatory agencies, policy makers, and other stakeholders can use this ranking when developing risk management strategies for the use of antimicrobials in food production animals. The ranking allows stakeholders to focus risk management efforts on drugs used in food animals that are the most important to human medicine and, thus, need to be addressed most urgently, such as fluoroquinolones, macrolides, and third- and fourth-generation cephalosporin

RESORCION DE HUESOS ALVEOLAR EN PACIENTES DIABÉTICOS TIPO II CON PERIODONTITIS CRÓNICA EN EL CENTRO DE SALUD PERÚ KOREA HUÁNUCO 2017

Las enfermedades periodontales comúnmente abarcan numerosos y complejos signos y síntomas, motivo por el cual existen diversos métodos diagnósticos para evaluar la condición y magnitud de éstas. El indicador más importante de la magnitud con que se presenta la enfermedad periodontal está basado en la reabsorción de hueso alveolar, por ser el que en última instancia se ve afectado. Objetivo: Determinar el grado y tipo de resorción de hueso alveolar en pacientes diabéticos tipo II con periodontitis crónica atendidos en el Centro de Salud Perú Corea Huánuco 2019. Materiales y Métodos: En este estudio se incluyeron 60 pacientes diabéticos pertenecientes al Centro de Salud Perú Corea Huánuco en los cuales se utilizaron un explorador y un espejo bucal que sirvió para visualizar el estado periodontal del paciente ,la toma de fotografías intraorales las que permitieron observar de forma directa la cavidad de acuerdo a la exposición radicular y ver el grado de resorción de hueso alveolar. Resultados: La investigación revela que, el grado de reabsorción de hueso alveolar en pacientes diabéticos tipo II. Se aprecia la distribución según el tipo de resorción los cuales están distribuidos de la siguiente manera: 58% ambos y 42% horizontal. Conclusiones: La diabetes mellitus tipo II influye significativamente en la resorción del hueso alveolar en pacientes diabéticos. (p<0.05).Tesi

Salmonella enterica serotype Typhimurium DT104 Isolated from Humans, United States, 1985, 1990, and 1996

First isolated from an ill person in 1985, multidrug-resistant Salmonella enterica serotype Typhimurium DT104 emerged in the mid-1990s as a strain of Salmonella frequently isolated from humans in the United States. We compared the integron content, plasmid profile, and XbaI pulsed-field gel electrophoresis (PFGE) patterns of multidrug-resistant S. Typhimurium DT104 (MR-DT104) isolated from humans in the United States in 1985, 1990, and 1996. All isolates contained a 60-mDa plasmid and had indistinguishable PFGE and integron profiles, supporting the idea of a clonal relationship between recent and historical isolates. The data suggest that the widespread emergence of MR-DT104 in humans and animals in the 1990s may have been due to the dissemination of a strain already present in the United States rather than the introduction of a new strain

The Routine Use of Antibiotics to Promote Animal Growth Does Little to Benefit Protein Undernutrition in the Developing World

Some persons argue that the routine addition of antibiotics to animal feed will help alleviate protein undernutrition in developing countries by increasing meat production. In contrast, we estimate that, if all routine antibiotic use in animal feed were ceased, there would be negligible effects in these countries. Poultry and pork production are unlikely to decrease by more than 2%. Average daily protein supply would decrease by no more than 0.1 g per person (or 0.2% of total protein intake). Eliminating the routine use of in-feed antibiotics will improve human and animal health, by reducing the development and spread of antibiotic-resistant bacteri

Drug-resistant Escherichia coli, Rural Idaho

Stool carriage of drug-resistant Escherichia coli in home-living residents of a rural community was examined. Carriage of nalidixic acid–resistant E. coli was associated with recent use of antimicrobial agents in the household. Household clustering of drug-resistant E. coli was observed. Most carriers of drug-resistant E. coli lacked conventional risk factors

Global Burden of Invasive Nontyphoidal Salmonella Disease, 2010

Nontyphoidal Salmonella is a major cause of bloodstream infections worldwide, and HIV-infected persons and malaria-infected and malnourished children are at increased risk for the disease. We conducted a systematic literature review to obtain age group–specific, population-based invasive nontyphoidal Salmonella (iNTS) incidence data. Data were categorized by HIV and malaria prevalence and then extrapolated by using 2010 population data. The case-fatality ratio (CFR) was determined by expert opinion consensus. We estimated that 3.4 (range 2.1–6.5) million cases of iNTS disease occur annually (overall incidence 49 cases [range 30–94] per 100,000 population). Africa, where infants, young children, and young adults are most affected, had the highest incidence (227 cases [range 152–341] per 100,000 population) and number of cases (1.9 [range 1.3–2.9] million cases). An iNTS CFR of 20% yielded 681,316 (range 415,164–1,301,520) deaths annually. iNTS disease is a major cause of illness and death globally, particularly in Africa. Improved understanding of the epidemiology of iNTS is needed

International Health Regulations—What Gets Measured Gets Done

Focus on goals and metrics for 4 core capacities illustrates 1 approach to implementing IHR

HIV infection as a risk factor for shigellosis.

We investigated cases of shigellosis in San Francisco and Alameda Counties identified during 1996 by active laboratory surveillance to assess the role of HIV infection as a risk factor for shigellosis. Dramatically elevated rates of shigellosis in HIV-infected persons implicate HIV infection as an important risk factor for shigellosis in San Francisco